122 related articles for article (PubMed ID: 38366813)
1. Assessment of SOX10 expression in 437 canine neoplasms of different embryologic origins.
Nelissen S; Miller AD
Vet Pathol; 2024 Feb; ():3009858241231562. PubMed ID: 38366813
[TBL] [Abstract][Full Text] [Related]
2. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Expression of
Tsoi MF; Thaiwong T; Smedley RC; Noland E; Kiupel M
Front Vet Sci; 2021; 8():701457. PubMed ID: 34422947
[TBL] [Abstract][Full Text] [Related]
4. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
5. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
6. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
7. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
8. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
9. SOX2 Expression in Canine Neoplasia.
Miranda IC; Miller AD
Vet Pathol; 2021 Sep; 58(5):964-970. PubMed ID: 32975490
[TBL] [Abstract][Full Text] [Related]
10. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
11. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
12. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
[TBL] [Abstract][Full Text] [Related]
13. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
Szumera-Ciećkiewicz A; Bosisio F; Teterycz P; Antoranz A; Delogu F; Koljenović S; van de Wiel BA; Blokx W; van Kempen LC; Rutkowski P; Christopher van Akkooi A; Cook M; Massi D;
Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.
Ginn PE
Vet Pathol; 1996 Sep; 33(5):533-41. PubMed ID: 8885180
[TBL] [Abstract][Full Text] [Related]
15. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY
Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
[TBL] [Abstract][Full Text] [Related]
16. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S
J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
[TBL] [Abstract][Full Text] [Related]
17. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors.
Aphivatanasiri C; Li J; Chan R; Jamidi SK; Tsang JY; Poon IK; Shao Y; Tong J; To KF; Chan SK; Tam F; Cheung SY; Shea KH; Tse GM
Breast Cancer Res Treat; 2020 Nov; 184(1):11-21. PubMed ID: 32737715
[TBL] [Abstract][Full Text] [Related]
18. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
Dermawan JKT; Underwood D; Policarpio-Nicolas ML
Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of SOX10 Expression in Human Pathology.
Bahmad HF; Thiravialingam A; Sriganeshan K; Gonzalez J; Alvarez V; Ocejo S; Abreu AR; Avellan R; Arzola AH; Hachem S; Poppiti R
Curr Issues Mol Biol; 2023 Dec; 45(12):10131-10158. PubMed ID: 38132479
[TBL] [Abstract][Full Text] [Related]
20. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]